UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~April~~May 1516, 2016

Foundation Healthcare, Inc.

(Exact name of registrant as specified in charter)

Oklahoma

001-34171

20-0180812

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

14000 N. Portland Avenue, Suite 200

Oklahoma City, Oklahoma 73134

(Address of Principal Executive Offices) (Zip Code)

(405) ~~601~~608-~~5300~~1700

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 52.02. ~~Departure~~Results of ~~Directors~~Operations orand ~~Certain~~Financial ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Condition.

~~Resignation~~On ofMay ~~Robert~~16, M2016, Foundation Healthcare, Inc. ~~Byers~~announced its financial results for the quarter ended March 31, 2016. A copy of the earnings press release is attached as ~~Advisor~~Exhibit 99.1 to ~~the~~this ~~Chairman~~Current Report on Form 8-K. A transcript of the ~~Board~~earnings conference call is attached as Exhibit 99.2 to this Current Report on Form 8-K.

OnThe ~~April~~information in this Current Report on Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section ~~15,~~18 ~~2016,~~of the ~~Robert~~Securities M.Exchange ~~Byers~~Act ~~resigned~~of ~~his~~1934 ~~position~~(the as“Exchange ~~Advisor~~Act”) or otherwise subject to the ~~Chairman~~liabilities of ~~the~~that ~~Board. We~~section, donor ~~not~~shall ~~anticipate~~it ~~naming~~be adeemed ~~new Advisor~~incorporated toby reference in any filing under the ~~Chairman~~Securities Act of 1933 or the ~~Board~~Exchange Act, except as expressly set forth by specific reference in such a filing.

~~SIGNATURES~~Item 7.01 Regulation FD Disclosure.

~~Pursuant~~On toMay ~~the~~17, ~~requirements~~2016, ofFoundation ~~the~~Healthcare, ~~Securities~~Inc. ~~Exchange~~(referred ~~Act~~to ofherein ~~1934~~as “we,” “us,” and “our”) distributed the ~~registrant~~slide show, ~~has~~attached ~~duly~~hereto ~~caused~~as ~~this~~Exhibit ~~report~~99.3 toand beincorporated ~~signed~~herein onby reference, in conjunction with its ~~behalf~~presentation byat the ~~undersigned hereunto~~Oppenheimer ~~duly~~Emerging ~~authorized~~Growth Conference in New York, New York.

Note Regarding Non-GAAP Financial Measures

The investor presentation attached as an exhibit hereto contains certain references to adjusted EBITDA value, which is a non-GAAP financial measure, as defined under Regulation G of the rules and regulations of the SEC.

Adjusted EBITDA

We are providing EBITDA information, which is defined as net income plus interest, income taxes, depreciation and amortization expense and earnings or losses from discontinued operations, and Adjusted EBITDA which is defined as EBITDA plus stock compensation expense. EBITDA and Adjusted EBITDA are a complement to our GAAP results. EBITDA and Adjusted EBITDA are commonly used by management and investors as a measure of leverage capacity, debt service ability and liquidity. EBITDA and Adjusted EBITDA are not considered a measure of financial performance under U.S. generally accepted accounting principles (GAAP), and the items excluded from EBITDA and Adjusted EBITDA are significant components in understanding and assessing our financial performance. EBITDA and Adjusted EBITDA should not be considered in isolation or as an alternative to, or superior to, such GAAP measures as net income, cash flows provided by or used in operating, investing or financing activities or other financial statement data presented in our consolidated financial statements as an indicator of financial performance or liquidity. Reconciliations of non-GAAP financial measures are provided in the investor presentation. Since EBITDA and Adjusted EBITDA are not a measure determined in accordance with GAAP and is susceptible to varying calculations, EBITDA, and Adjusted EBITDA as presented, may not be comparable to other similarly titled measures of other companies.

Item 9.01. Financial Statements and Exhibits.

(d)	Exhibits.


Exhibit No.		Description

99.1		Earnings Press Release Issued on May 16, 2016

99.2		Transcript of May 16, 2016 Earnings Conference Call

99.3		Investor Presentation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXHIBIT INDEX


Exhibit No.		Exhibit

99.1		Earnings Press Release Issued on May 16, 2016

99.2		Transcript of May 16, 2016 Earnings Conference Call

99.3		Investor Presentation

FOUNDATION HEALTHCARE, INC.

Date: April 19, 2016

/s/ STANTON NELSON

Stanton Nelson

Chief Executive Officer

Filing Compare · Foundation Healthcare, Inc.